TickerFacts.

Lucid Diagnostics Inc. (LUCD): Revenue

Annual figures by period end, from SEC filings.

$4.71M
Year ended 2025-12-31
$5.45M
Trailing 12 months to 2026-06-30
+132.0%
3-year compound annual growth
2021-12-31: $500.0K2022-12-31: $377.0K2023-12-31: $2.43M2024-12-31: $4.35M2025-12-31: $4.71M$4.71M
2021-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$4.71M+8.3%2026-03-25, From 2025-01-01
2024-12-31$4.35M+79.0%2026-03-25, From 2024-01-01
2023-12-31$2.43M+544.0%2025-03-24, From 2023-01-01
2022-12-31$377.0K-24.6%2024-03-25, From 2022-01-01
2021-12-31$500.0Kn/a2023-03-14, From 2021-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Lucid Diagnostics Inc. (LUCD)2025-12-31$4.71M+8.3%
Picard Medical, Inc. (PMI)2025-12-31$4.94M+12.5%
Cerenome, Inc. (CNSY)2025-12-31$5.21M-10.5%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$4.22M+38.1%
Tenon Medical, Inc. (TNON)2025-12-31$3.94M+20.4%
IceCure Medical Ltd. (ICCM)2025-12-31$3.38M+2.7%
Encision Inc (ECIA)2025-03-31$6.56M-0.5%
Nuo Therapeutics, Inc. (AURX)2025-12-31$3.31M+142.7%
INVO Fertility, Inc. (IVF)2025-12-31$6.84M+4.7%

Compare LUCD, PMI, CNSY, INBS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗